Stock Analiz

Medpace Holdings, Inc. (MEDP) stock forecast and price target

Price $653.94 · data as of November 13, 2026

12-month price target

Average target$651.31
Upside / downside−0.4%
Analysts13
ConsensusNone
Low $370.00Average $651.31High $730.00

Gold marker: average target · white marker: today’s price ($653.94)

Analyst ratings

Strong buy 1Buy 1Hold 11Sell 1Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$18.36+20.2%$2.8B
Next fiscal year
ends December 31, 2027
$19.85+8.1%$3.0B
Next quarter
ends December 31, 2026
$4.88+4.4%$718M
Quarter after
ends March 31, 2027
$4.66+8.8%$727M

Consensus of the analysts covering Medpace, updated daily. In the last 30 days 10 estimates were raised and 0 lowered.

Our model vs. Wall Street

Analysts see 0.4% downside over 12 months. Our discounted cash flow model with moderate assumptions puts Medpace’s intrinsic value about 32% below today’s market value, and it scores 3.2 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the Medpace stock price target?

The average 12-month target from 13 analysts is $651.31, 0.4% below the current price of $653.94 Targets range from $370.00 to $730.00.

Is Medpace a buy according to analysts?

The consensus rating is “None” (1 strong buy, 1 buy, 11 hold, 1 sell). Ratings are opinions, not guarantees; this is not investment advice.

How much is Medpace expected to earn?

Analysts expect EPS of $18.36 for the fiscal year ending December 31, 2026 and $19.85 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.